Client Situation
Our client, a leading infectious disease vaccine manufacturer, sought to understand the current recommendation process for adult pneumococcal vaccines in key markets, identify unmet needs, assess payer and VTC value perceptions, price potential and applicable funding pathways for two new PCV-20 vaccines. Additionally, they explored the impact of vaccine launch sequence on the price potential